NorthStar Asset Management (Pennsylvania)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $353K | Hold |
1,875
| – | – | 0.07% | 116 |
|
|
2026
Q1 | $317K | Hold |
1,875
| – | – | 0.07% | 120 |
|
|
2025
Q4 | $316K | Hold |
1,875
| – | – | 0.07% | 120 |
|
|
2025
Q3 | $271K | Hold |
1,875
| – | – | 0.06% | 128 |
|
|
2025
Q2 | $237K | Sell |
1,875
-300
| -14% | -$36.8K | 0.05% | 136 |
|
|
2025
Q1 | $278K | Sell |
2,175
-300
| -12% | -$40.7K | 0.07% | 129 |
|
|
2024
Q4 | $327K | Hold |
2,475
| – | – | 0.08% | 119 |
|
|
2024
Q3 | $360K | Hold |
2,475
| – | – | 0.08% | 118 |
|
|
2024
Q2 | $340K | Hold |
2,475
| – | – | 0.08% | 119 |
|
|
2024
Q1 | $340K | Hold |
2,475
| – | – | 0.08% | 122 |
|
|
2023
Q4 | $336K | Sell |
2,475
-450
| -15% | -$54.9K | 0.09% | 115 |
|
|
2023
Q3 | $358K | Sell |
2,925
-70
| -2% | -$8.9K | 0.1% | 103 |
|
|
2023
Q2 | $380K | Hold |
2,995
| – | – | 0.1% | 103 |
|
|
2023
Q1 | $387K | Sell |
2,995
-465
| -13% | -$60.9K | 0.11% | 104 |
|
|
2022
Q4 | $454K | Hold |
3,460
| – | – | 0.14% | 88 |
|
|
2022
Q3 | $405K | Hold |
3,460
| – | – | 0.14% | 94 |
|
|
2022
Q2 | $407K | Hold |
3,460
| – | – | 0.13% | 94 |
|
|
2022
Q1 | $451K | Hold |
3,460
| – | – | 0.12% | 95 |
|
|
2021
Q4 | $528K | Sell |
3,460
-60
| -2% | -$9.29K | 0.12% | 96 |
|
|
2021
Q3 | $569K | Hold |
3,520
| – | – | 0.15% | 90 |
|
|
2021
Q2 | $576K | Hold |
3,520
| – | – | 0.15% | 89 |
|
|
2021
Q1 | $530K | Sell |
3,520
-150
| -4% | -$23.8K | 0.15% | 91 |
|
|
2020
Q4 | $556K | Sell |
3,670
-105
| -3% | -$15K | 0.16% | 86 |
|
|
2020
Q3 | $511K | Hold |
3,775
| – | – | 0.16% | 84 |
|
|
2020
Q2 | $516K | Sell |
3,775
-420
| -10% | -$53.5K | 0.18% | 79 |
|
|
2020
Q1 | $452K | Buy |
4,195
+235
| +6% | +$27.1K | 0.21% | 77 |
|
|
2019
Q4 | $477K | Sell |
3,960
-200
| -5% | -$22.3K | 0.18% | 79 |
|
|
2019
Q3 | $414K | Buy |
4,160
+25
| +0.6% | +$2.62K | 0.16% | 83 |
|
|
2019
Q2 | $451K | Buy |
4,135
+75
| +2% | +$7.98K | 0.18% | 83 |
|
|
2019
Q1 | $454K | Buy |
4,060
+100
| +3% | +$11K | 0.18% | 84 |
|
|
2018
Q4 | $382K | Sell |
3,960
-1,910
| -33% | -$203K | 0.18% | 80 |
|
|
2018
Q3 | $715K | Buy |
5,870
+20
| +0.3% | +$2.35K | 0.28% | 72 |
|
|
2018
Q2 | $642K | Sell |
5,850
-435
| -7% | -$46.5K | 0.27% | 72 |
|
|
2018
Q1 | $671K | Buy |
6,285
+270
| +4% | +$29.9K | 0.28% | 73 |
|
|
2017
Q4 | $642K | Hold |
6,015
| – | – | 0.27% | 73 |
|
|
2017
Q3 | $669K | Buy |
6,015
+180
| +3% | +$19.2K | 0.29% | 74 |
|
|
2017
Q2 | $603K | Buy |
5,835
+165
| +3% | +$16.3K | 0.27% | 76 |
|
|
2017
Q1 | $554K | Sell |
5,670
-300
| -5% | -$28.7K | 0.25% | 79 |
|
|
2016
Q4 | $528K | Sell |
5,970
-375
| -6% | -$34.1K | 0.24% | 78 |
|
|
2016
Q3 | $613K | Sell |
6,345
-225
| -3% | -$21.4K | 0.26% | 75 |
|
|
2016
Q2 | $564K | Hold |
6,570
| – | – | 0.23% | 79 |
|
|
2016
Q1 | $571K | Buy |
+6,570
| New | +$588K | 0.24% | 77 |
|
Other funds holding IBB
WA
AFG
NorthStar Asset Management (Pennsylvania)'s IBB Position: Q2 2026 in Review
NorthStar Asset Management (Pennsylvania) held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,875 shares worth $353K. The position accounts for 0.07% of the portfolio, ranked #116.
NorthStar Asset Management (Pennsylvania) first reported a position in IBB in Q1 2016 and has held it in 42 quarters since. The position peaked at $715K in Q3 2018. 601 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- NorthStar Asset Management (Pennsylvania) held 1,875 shares of iShares Biotechnology ETF worth $353K as of Q2 2026.
- NorthStar Asset Management (Pennsylvania) left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up 0.07% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q2 2026, its #116 holding.
- NorthStar Asset Management (Pennsylvania) first reported a position in iShares Biotechnology ETF in Q1 2016 and has held it in 42 quarters since.
- NorthStar Asset Management (Pennsylvania)'s iShares Biotechnology ETF position peaked at $715K in Q3 2018.
- 601 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2026, filed 27 Jul 2026.